Telitacicept in Primary APS Patients

Stopped There is no clear therapeutic effect among the enrolled patients for the time being.

Conditions

• Anti Phospholipid Syndrome

Interventions

• DRUG: Telitacicept

Sponsor

Peking Union Medical College Hospital